CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Aster DM reacts positive on COVID-19 confirmatory test initiation
Pratik Shastri
/ Categories: Trending, DSIJ News

Aster DM reacts positive on COVID-19 confirmatory test initiation

The shares of healthcare company-Aster DM Healthcare were trading higher with gains of more than five per cent on Thursday, after the company announced that it has started conducting COVID-19 tests.

On Wednesday after the market hours, the company made an announcement on stock exchanges about the company's clinical arm, Aster Clinical Lab LLP. It stated that the latter has started providing RT-PCR confirmatory test services for COVID-19 in Bengaluru (Karnataka). The development is considered very important due to the fact that the city is showing strong signs of revival from the lockdown and other restrictions. In such a scenario, continuing testing across the city becomes an essential part of the control measures as well as for keeping a check on the spread of COVID-19 infection through fast identification, quarantine, isolation and treatment.

The statement from the company further added that its lab facility is fully-equipped; having advanced instruments used in various routine as well as specialised investigations. With a purpose to serve these tests and investigations, the company has set up its pathology reference laboratory which will cater biochemistry, haematology, microbiology, molecular diagnostics, cytogenetics and digital histopathology-related investigations.

At 11 am on Thursday, the stock price traded at Rs 100 per share with gains of 5.6 per cent on BSE.

Previous Article Five stocks with buying interest
Next Article Deepak Nitrite: Creating The Right Chemistry
Print
837 Rate this article:
3.8
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR